Outcomes Rocket · 2026-06-22 · 12 min
Lung cancer biopsies are still being done blind more often than you’d think, leading to costly diagnostic errors. In this episode, Reza Khorasaninejad, Founder & CEO at LEADOPTIK, discusses how advances in photonics and metasurface engineering are enabling highly miniaturized imaging systems for minimally invasive procedures. These innovations aim to address a major challenge in lung cancer biopsies: a lack of imaging guidance that can lead to significant diagnostic errors. Early clinical pilots across multiple sites are demonstrating strong performance, with one hospital already converting into a paying customer. Looking ahead, the company is partnering with Stanford Medicine to develop AI-driven decision support tools to further improve diagnostic accuracy. Tune in to learn how next-generation imaging and AI are changing that reality and helping physicians hit the right target the first time! Resources:
Why Customer Success Is the Next Major Category in MedTech with Rupal Ayer, Senior Director of Customer Success at Solventum63 / 100
Closing the Treatment Gap for Patients Living with Tremor with Deanna Harshbarger, CEO of Cala Health
Changing the Clinical Value Equation in Orthopedic Care with Nic Aldrich, Vice President of Marketing at OrthAlign
Using AI to Strengthen Clinical Confidence in Procedures with Will Mauldin, Co-Founder and CEO of Rivanna Medical
Building Bridges Across the Healthcare Ecosystem with Adam McMullin, CEO of AvaSure